Latest Biologic Stories
- Hospira calls for continued support of extrapolation principle to help drive increased patient access to life-saving biologic medicines - LONDON, April 24, 2015 /PRNewswire/ --
Catalent, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced the launch of ADVASEPT™ Lock,
DALLAS, April 21, 2015 /PRNewswire/ -- According to a new market research report "Biologics Safety Testing Market by Application (Stem Cell, Blood, Gene Therapy), Product
Catalent’s Zydis® Technology Used to Develop Thermo Stable and Cold-Chain Independent Vaccines Somerset, NJ (PRWEB) April 20, 2015 Catalent, the
INDIANAPOLIS, April 20, 2015 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the investigational medicine ixekizumab was statistically superior to placebo in the treatment
Biosimilars Council Releases First Biosimilars Handbook for U.S.
PORTLAND, Oregon, April 16, 2015 /PRNewswire/ -- A new report by Allied Market Research, titled, "Global Intravenous Immunoglobulin (IVIG) Market - Size, Industry Analysis,
Disability Community Calls for Consumer Safeguards and Guidance from FDA for New Category of Biologic Drugs WASHINGTON, April 16, 2015 /PRNewswire-USNewswire/ --
BEIJING, April 16, 2015 /PRNewswire/ -- China Biologic Products, Inc.
- A hairdresser.